Filing Impact
Filing Sentiment
Form Type
144
Ocugen Inc
Sep 2, 2025
Ocugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025
Aug 12, 2025
Ocugen, Inc. Announces Closing of $20 Million Registered Direct Offering of Common Stock and Warrants
Sep 5, 2025
[8-K] Ocugen, Inc. Reports Material Event
Aug 11, 2025
[8-K] Ocugen, Inc. Reports Material Event
Aug 4, 2025
[10-Q] Ocugen, Inc. Quarterly Earnings Report
Aug 1, 2025
[8-K] Ocugen, Inc. Reports Material Event
321.67M
307.64M
1.49%
16.69%
18.73%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
MALVERN